Back to search results

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of California Los Angeles (UCLA), Los Angeles, California, United States

  • UC Irvine Health, Orange, California, United States

  • Colorado Blood Cancer Institute/SCRI, Denver, Colorado, United States

  • Norton Cancer Institute, Louisville, Kentucky, United States

  • Karmanos Cancer Institute, Detroit, Michigan, United States

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York, United States

  • Perlmutter Cancer Center, New York, New York, United States

  • Columbia University _ New York Presbyterian, New York, New York, United States

  • Stony Brook University Hospital, Stony Brook, New York, United States

  • Levine Cancer Institute, Charlotte, North Carolina, United States

  • Duke University Health System (DUHS), Durham, North Carolina, United States

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, Vienne, France

  • CHU De Lille, Lille, France

  • Centre Hospitalier Universitaire (CHU) Montpellier, Montpellier, France

  • Hopital Saint Louis, Paris, France

  • University Hospitals Pitie Salpetriere - Charles Foix, Paris, France

  • Hopital Prive d'Antony, Antony, Île-de-France Region, France

  • Hopital Necker, Paris, Île-de-France Region, France

  • Gustave Roussy, Villejuif, Île-de-France Region, France

  • Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

  • Hospital Universitario Quiron Salud Madrid, Pozuelo de Alarcón, Madrid, Spain

  • Clinica Universidad de Navarra, Pamplona, Navarre, Spain

  • Hospital Universitario Central de Asturias, Oviedo, Principality of Asturias, Spain

  • Hospital General Universitario Doctor Balmis Alicante, Alicante, Valencia, Spain

  • Hospital Clinic de Barcelona, Barcelona, Spain

  • Institut Catala dOncologia (ICO Hospitalet), Barcelona, Spain

  • Universitary Hospital La Princesa, Madrid, Spain

  • Clinica Universidad de Navarra - Madrid, Madrid, Spain

  • Hospital Universitario de Salamanca, Salamanca, Spain

  • Hospital Universitari i Politecnic La Fe, Valencia, Spain

Study leads

  • Clinical Trial Management

    Study Director

    Regeneron Pharmaceuticals

View source on ClinicalTrials.gov(opens in a new tab)